Impact on time until deterioration of health-related quality of life of a first-line therapy combining ABI-007 and gemcitabine or simplified LV5FU2 in patients with metastatic pancreatic cancer: results of clinical phase II trial AFUGEM
| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | Impact on time until deterioration of health-related quality of life of a first-line therapy combining ABI-007 and gemcitabine or simplified LV5FU2 in patients with metastatic pancreatic cancer: results of clinical phase II trial AFUGEM |
| Type de publication | Journal Article |
| Year of Publication | 2016 |
| Auteurs | Charton E, Bachet J-B, Chibaudel B, Validire P, Hammel P, Andre T, Louvet C, Anota A, Bonnetain F |
| Journal | QUALITY OF LIFE RESEARCH |
| Volume | 25 |
| Pagination | 59-60 |
| Date Published | OCT |
| Type of Article | Meeting Abstract |
| ISSN | 0962-9343 |